Patents
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
11/2006
11/28/2006US7141668 from mixtures comprising caprolactam, water, light components including unsaturated lactams and heavy components, by vacuum distillation, then hydrogenating the unsaturated lactams
11/28/2006US7141588 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
11/28/2006US7141573 Huntington's diseases, Alzheimer's diseases, psychological disorders
11/28/2006CA2113603C Tricyclic condensed heterocyclic compounds, their production and use
11/23/2006WO2006029154A3 Novel compounds
11/23/2006US20060264418 6-(2,2,2-Trifluoroethylamino-7-chloro-2,3,4,5-tetrahydro-1h-benzo[d] azephine as a 5-ht2c receptor agonist
11/23/2006US20060264417 N-(3-tetrahydrobenzodiazepinonyl)succamides: 2R,3S)N1-[1,3,4,5-tetrahydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,5-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; inhibit production of A beta -peptide, preventing neurological amyloid deposits; Alzheimer's disease
11/22/2006EP1554243B1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases
11/22/2006EP1511770B1 Glycoprotein vi-fc fusion protein for the treatment of vascular diseases
11/22/2006EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006EP1238970B1 Cycloamine ccr5 receptor antagonists
11/22/2006CN1285568C Method of evaporating cyclohexanone oxime
11/21/2006US7138533 acetylcholinesterase inhibitory action and an alpha 1 antagonistic action
11/21/2006US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/21/2006CA2247257C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
11/16/2006WO2006088541A3 Quinoline derivatives and uses thereof
11/16/2006WO2005117882A3 Hydroxamic acid derivatives as metalloprotease inhibitors
11/16/2006US20060258704 2-Oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders
11/16/2006US20060258666 c-fms kinase inhibitors
11/16/2006US20060258638 Succinoylamino lactams as inhibitors of A-beta protein production
11/15/2006EP1720836A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo [d]azepines as 5-ht2c receptor agonists
11/15/2006EP1720827A1 Method of preparing benzazepines and derivatives thereof
11/15/2006EP1411881B9 5ht2c receptor modulators
11/15/2006EP1323711B1 Novel phenylalanine derivatives
11/15/2006CN1863778A Compounds and methods for treating dyslipidemia
11/15/2006CN1862871A Electrolytic solution and battery
11/15/2006CN1284774C Process for distilling alkaline caprolactam product at reduced pressure
11/14/2006CA2128955C Tricyclic benzazepine vasopressin antagonists
11/14/2006CA2128493C Aminobenzoic acid derivatives
11/08/2006EP1021190B1 Amid derivatives as growth hormone release promotors
11/07/2006US7132551 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome
11/07/2006US7132547 Preventives/remedies for urinary disturbance
11/02/2006EP1716118A1 Tetrahydrobenzo[d]azepin-2- one derivatives and the use thereof for treating cardiovascular diseases
11/01/2006CN1856486A Substituted lactams and their use as anti-cancer agents
11/01/2006CN1856313A Therapeutic compounds
10/2006
10/31/2006US7129228 Heterocyclic analgesic compounds and methods of use thereof
10/31/2006CA2246126C New piperazine compounds
10/26/2006US20060241292 Method of preparing a 5H-dibenz(b,f)azepine-5-carboxamide
10/25/2006EP1713778A1 Benzazepine derivatives as histamine h3 antagonists
10/25/2006CN1852748A Azepine derivatives as pharmaceutical agents
10/25/2006CN1850804A Optical-purity meptazinol orits salts, and preparing method
10/25/2006CN1281605C Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/24/2006US7125987 Process for the preparation of oxcarbazepine and related intermediates
10/24/2006CA2261848C Cell adhesion inhibitors
10/18/2006EP1712549A1 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same
10/18/2006EP1711470A1 Malonamide derivatives blocking the activtiy of gamma-secretase
10/17/2006US7122538 Neuroleptic agents for treating schizophrenia, psychological disorders, depression; 5-(4-Chlorophenyl)-thiophene-2-sulfonic acid (8-methoxy-3-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)amide
10/17/2006US7122506 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides
10/17/2006CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
10/12/2006WO2006060225A3 Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds
10/12/2006US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/12/2006US20060229297 (THIO) Carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists
10/11/2006EP1708999A1 Bronchorelaxing compounds
10/11/2006CN1844102A Process for preparing Benazepril hydrochloride materials
10/11/2006CN1279044C Non-steroidal progesterone receptor modulators
10/11/2006CN1278688C oral dispersion pharmaceutical composition comprising ivabradine
10/10/2006US7119197 Reacting racemic (+-)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide with (2R,3R)-di-O,O'-substituted-tartaric acid anhydride; precipitation of less soluble diastereoisomeric 10-O-di-O,O'-substituted-tartrate half-ester; hydrolysis
10/05/2006WO2006104280A1 Prophylactic/therapeutic agent for diabetes
10/05/2006WO2006104226A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING α-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME
10/05/2006US20060223802 Derivatives of N-[phenyl(pyrrolidine-2-yl)methyl]benzamide and N-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics
10/05/2006US20060223784 Method and compositions for temporarily incapacitating subjects
10/05/2006CA2603122A1 Phenyl and pyridyl lta4h modulators
10/04/2006EP1707562A1 Crystalline form gamma of the chlorhydrate of ivabradine, process for its preparation and pharamcetuical composition containing it
10/04/2006EP1706501A2 Biochemical synthesis of 6-amino caproic acid
10/04/2006EP1706402A1 Cathepsin cysteine protease inhibitors
10/04/2006EP1423392B1 Derivatives of morphine-like opioid compounds
10/04/2006EP1372653B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists
10/04/2006CN1842515A Cathepsin inhibitors
10/04/2006CN1277818C Process for recovering caprolactam
10/03/2006US7115192 Apparatus and process for the synthesis of hydrogen peroxide directly from hydrogen and oxygen
09/2006
09/28/2006WO2006101871A1 Process for making caprolactam
09/28/2006WO2006101870A1 Improved method for making caprolactam from impure 6-aminocapronitrile
09/28/2006WO2006047503A3 Inhibitors of c-fms kinase
09/28/2006CA2600770A1 Process for making caprolactam
09/28/2006CA2600769A1 Improved method for making caprolactam from impure 6-aminocapronitrile
09/27/2006EP1705176A1 Carboxamide derivative and use thereof
09/27/2006EP1704142A1 Protease inhibitors
09/26/2006US7112673 Dibenzo [b,f]azepine intermediates
09/26/2006US7112583 Containing a benzodiazepine ring, e.g., (2(R)-Cyclopentylmethyl-3(S)-hydroxyl-1-oxo-5-phenylpentyl)amino-1-methyl-5-(4-fluoro-phenyl)-2,3-dihydro-1H-1,5-benzodiazepin-2-one; treating Alzheimer's disease and Down's Syndrome
09/21/2006WO2006079090A3 Process for the preparation of fenoldopam mesylate
09/21/2006US20060211679 Substituted lactams as inhibitors of Abeta protein production
09/21/2006US20060211675 Preventives/remedies for urinary disturbance
09/20/2006CN1835926A Process for the preparation of nonpeptide substituded spirobenzoazepine derivatives
09/20/2006CN1835925A Substituted spirobenzazepines
09/20/2006CN1835914A New benzamides as PPAR[upsilon] modulators
09/20/2006CN1275945C Meptazinol ortho-propionyloxy-cis-benzyl acrylate and its salts and their production method
09/14/2006WO2006053674A3 A process for the preparation of 10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxyamide
09/14/2006US20060205772 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type I
09/13/2006EP1699764A1 Bis-dicarboxylic acid salts of benazepril and preparation of benazepril via these salts
09/13/2006CN1832926A 6-(2,2,2-trifluoroethylamino)-7-chloro-2,3,4,5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist
09/13/2006CN1274692C Total synthesizing meethod for pyrrole heterocyclic alkaloid aldisin
09/13/2006CN1274670C Diaminopropionic acid derivatives
09/12/2006US7105508 Integrin receptors antagonists
09/08/2006WO2006093269A1 Optically active ammonium salt compound, production intermediate thereof and method for producing same
09/08/2006WO2006092493A1 $g(b) crystalline form of ivabradine hydrochloride, preparation method thereof and pharmaceutical compositions containing same
09/06/2006EP1345607B1 Therapeutic combination of amlodipine and benazepril / benazeprilat
09/06/2006CN1829703A (Thio)carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists
09/06/2006CN1829696A Process for preparation of benazepril
09/06/2006CN1827733A Organic electroluminescence device
09/06/2006CN1827602A Crystalline form gamma of the chlorhydrate of ivabradine, process for its preparation and phamaceutical composition containing it
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 88